Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anders Hamsten
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Physiology
Concepts & Ideas
Procedures
Genes & Molecular Sequences
Geographic Areas
Sign-in to see full Profile
Network (preview)
63
Eriksson, Per
44
Karpe, Fredrik
43
Silveira, Angela
39
Tornvall, Per
38
de Faire, Ulf
29
Fisher, Rachel
26
Ericsson, Carl-Göran
21
Boquist, Susanna
18
Ehrenborg, Ewa
18
Yki-Järvinen, Hannele
14
Björkegren, Johan
13
Båvenholm, Peter
13
Samnegård, Ann
12
Nilsson, Jan
11
Lundman, Pia
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anders Hamsten (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Mälarstig Anders; Buil Alfonso; Souto Juan Carolos; Clarke Robert; Blanco-Vaca Francisco; Fontcuberta Jordi; Peden John; Andersen Malin; Silveira Angela; Barlera Simona; Seedorf Udo; Watkins Hugh; Almasy Laura; Hamsten Anders; Soria José Manuel;
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study.
Blood 2009;114(7):1417-22.
-
2009: Kotronen A; Johansson L E; Johansson L M; Roos C; Westerbacka J; Hamsten A; Bergholm R; Arkkila P; Arola J; Kiviluoto T; Fisher R M; Ehrenborg E; Orho-Melander M; Ridderstråle M; Groop L; Yki-Järvinen H
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.
Diabetologia 2009;52(6):1056-60.
-
2009: Gigante Bruna; Vikström Max; Meuzelaar Linda Strömqvist; Chernogubova Ekaterina; Silveira Angela; Hooft Ferdinand Van't; Hamsten Anders; de Faire Ulf
Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
Thrombosis and haemostasis 2009;101(5):943-53.
-
2009: Kotronen Anna; Yki-Järvinen Hannele; Aminoff Anna; Bergholm Robert; Pietiläinen Kirsi H; Westerbacka Jukka; Talmud Philippa J; Humphries Steve E; Hamsten Anders; Isomaa Bo; Groop Leif; Orho-Melander Marju; Ehrenborg Ewa; Fisher Rachel M
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(4):593-602.
-
2009: Olofsson P S; Söderström L A; Jern C; Sirsjö A; Ria M; Sundler E; de Faire U; Wiklund P G; Ohrvik J; Hedin U; Paulsson-Berne G; Hamsten A; Eriksson P; Hansson G K
Genetic variants of TNFSF4 and risk for carotid artery disease and stroke.
Journal of molecular medicine (Berlin, Germany) 2009;87(4):337-46.
-
2009: Sierra-Johnson Justo; Romero-Corral Abel; Somers Virend K; Lopez-Jimenez Francisco; Mälarstig Anders; Brismar Kerstin; Hamsten Anders; Fisher Rachel M; Hellénius Mai-Lis
IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.
Clinical science (London, England : 1979) 2009;116(6):507-12.
-
2009: Sierra-Johnson Justo; Fisher Rachel M; Romero-Corral Abel; Somers Virend K; Lopez-Jimenez Francisco; Ohrvik John; Walldius Göran; Hellenius Mai-Lis; Hamsten Anders
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
European heart journal 2009;30(6):710-7.
-
2009: Kärvestedt Lars; Mårtensson Eva; Grill Valdemar; Elofsson Stig; von Wendt Gunvor; Hamsten Anders; Brismar Kerstin
Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden.
Diabetes care 2009;32(2):317-22.
-
2009: Samnegård Ann; Hulthe Johannes; Silveira Angela; Ericsson Carl-Göran; Hamsten Anders; Eriksson Per
Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients.
Atherosclerosis 2009;202(2):550-6.
-
2009: Folkersen Lasse; Kyriakou Theodosios; Goel Anuj; Peden John; Mälarstig Anders; Paulsson-Berne Gabrielle; Hamsten Anders; Hugh Watkins; Franco-Cereceda Anders; Gabrielsen Anders; Eriksson Per;
Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants.
PloS one 2009;4(11):e7677.
-
2008: Sjögren Per; Fredrikson Gunilla N; Samnegard Ann; Ericsson Carl-Göran; Ohrvik John; Fisher Rachel M; Nilsson Jan; Hamsten Anders
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
European heart journal 2008;29(18):2218-26.
-
2008: Sevastianova Ksenia; Sutinen Jussi; Kannisto Katja; Hamsten Anders; Ristola Matti; Yki-Järvinen Hannele
Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
American journal of physiology. Endocrinology and metabolism 2008;295(1):E85-91.
-
2008: Hägg Daniel A; Jernås Margareta; Wiklund Olle; Thelle Dag S; Fagerberg Björn; Eriksson Per; Hamsten Anders; Olsson Bob; Carlsson Björn; Carlsson Lena M S; Svensson Per-Arne
Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes.
International journal of molecular medicine 2008;21(6):697-704.
-
2008: Mälarstig A; Eriksson P; Hamsten A; Lindahl B; Wallentin L; Siegbahn A
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome.
Heart (British Cardiac Society) 2008;94(6):724-9.
-
2008: Hamsten A; Eriksson P
Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.
Journal of internal medicine 2008;263(5):538-52.
-
2008: Greco Dario; Kotronen Anna; Westerbacka Jukka; Puig Oscar; Arkkila Perttu; Kiviluoto Tuula; Laitinen Saara; Kolak Maria; Fisher Rachel M; Hamsten Anders; Auvinen Petri; Yki-Järvinen Hannele
Gene expression in human NAFLD.
American journal of physiology. Gastrointestinal and liver physiology 2008;294(5):G1281-7.
-
2008: Mälarstig Anders; Eriksson Per; Rose Lynda; Diehl Kirsti A; Hamsten Anders; Ridker Paul M; Zee Robert Y L
Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.
Clinical chemistry 2008;54(5):833-40.
-
2008: Mälarstig Anders; Sigurdsson Snaevar; Eriksson Per; Paulsson-Berne Gabrielle; Hedin Ulf; Wallentin Lars; Siegbahn Agneta; Hamsten Anders; Syvänen Ann-Christine
Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(5):975-82.
-
2008: Krapivner Sergey; Popov Sergej; Chernogubova Ekaterina; Hellénius Mai-Lis; Fisher Rachel M; Hamsten Anders; van't Hooft Ferdinand M
Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation.
The Journal of clinical endocrinology and metabolism 2008;93(5):1995-2001.
-
2008: Westerbacka Jukka; Cornér Anja; Kolak Maria; Makkonen Janne; Turpeinen Ursula; Hamsten Anders; Fisher Rachel M; Yki-Järvinen Hannele
Insulin regulation of MCP-1 in human adipose tissue of obese and lean women.
American journal of physiology. Endocrinology and metabolism 2008;294(5):E841-5.
-
2008: Skogsberg Josefin; Lundström Jesper; Kovacs Alexander; Nilsson Roland; Noori Peri; Maleki Shohreh; Köhler Marina; Hamsten Anders; Tegnér Jesper; Björkegren Johan
Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes.
PLoS genetics 2008;4(3):e1000036.
-
2008: Sjögren Per; Fredrikson Gunilla N; Rosell Magdalena; de Faire Ulf; Hamsten Anders; Nilsson Jan; Hellenius Mai-Lis; Fisher Rachel M
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
Metabolism: clinical and experimental 2008;57(3):362-6.
-
2008: Broadbent Helen M; Peden John F; Lorkowski Stefan; Goel Anuj; Ongen Halit; Green Fiona; Clarke Robert; Collins Rory; Franzosi Maria Grazia; Tognoni Gianni; Seedorf Udo; Rust Stephan; Eriksson Per; Hamsten Anders; Farrall Martin; Watkins Hugh;
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.
Human molecular genetics 2008;17(6):806-14.
-
2008: Sjögren P; Sierra-Johnson J; Gertow K; Rosell M; Vessby B; de Faire U; Hamsten A; Hellenius M-L; Fisher R M
Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance.
Diabetologia 2008;51(2):328-35.
-
2008: Wågsäter Dick; Björk Hanna; Zhu Chaoyong; Björkegren Johan; Valen Guro; Hamsten Anders; Eriksson Per
ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques.
Atherosclerosis 2008;196(2):514-22.
-
2008: Boquist S; Ruotolo G; Skoglund-Andersson C; Tang R; Björkegren J; Bond M G; de Faire U; Brismar K; Hamsten A
Correlation of serum IGF-I and IGFBP-1 and -3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men.
Clinical endocrinology 2008;68(1):51-8.
-
2008: Skogsberg Josefin; Dicker Andrea; Rydén Mikael; Aström Gaby; Nilsson Roland; Bhuiyan Hasanuzzaman; Vitols Sigurd; Mairal Aline; Langin Dominique; Alberts Peteris; Walum Erik; Tegnér Jesper; Hamsten Anders; Arner Peter; Björkegren Johan
ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes.
PloS one 2008;3(11):e3771.
-
2007: van Rooijen Marianne; Silveira Angela; Thomassen Stella; Odeberg Jacob; Hamsten Anders; Rosing Jan; Bremme Katarina
APC resistance during the normal menstrual cycle.
Thrombosis and haemostasis 2007;98(6):1246-51.
-
2007: Sjögren Per; Basta Giuseppina; de Caterina Raffaele; Rosell Magdalena; Basu Samar; Silveira Angela; de Faire Ulf; Vessby Bengt; Hamsten Anders; Hellenius Mai-Lis; Fisher Rachel M
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men.
Atherosclerosis 2007;195(2):e168-75.
-
2007: Hamad Rangeen Rafik; Eriksson Maria J; Silveira Angela; Hamsten Anders; Bremme Katarina
Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy.
Journal of hypertension 2007;25(11):2301-7.
-
2007: Sierra-Johnson Justo; Romero-Corral Abel; Somers Virend K; Lopez-Jimenez Francisco; Walldius Göran; Hamsten Anders; Hellénius Mai-Lis; Fisher Rachel M
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
European heart journal 2007;28(21):2637-43.
-
2007: Westerbacka Jukka; Kolak Maria; Kiviluoto Tuula; Arkkila Perttu; Sirén Jukka; Hamsten Anders; Fisher Rachel M; Yki-Järvinen Hannele
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
Diabetes 2007;56(11):2759-65.
-
2007: Morange P E; Saut N; Alessi M C; Yudkin J S; Margaglione M; Di Minno G; Hamsten A; Humphries S E; Tregouet D A; Juhan-Vague I
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(10):2250-7.
-
2007: Makkonen J; Westerbacka J; Kolak M; Sutinen J; Cornér A; Hamsten A; Fisher R M; Yki-Järvinen H
Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
International journal of obesity (2005) 2007;31(10):1617-25.
-
2007: Folkesson Maggie; Kazi Monsur; Zhu Chaoyong; Silveira Angela; Hemdahl Anne-Louise; Hamsten Anders; Hedin Ulf; Swedenborg Jesper; Eriksson Per
Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms.
Thrombosis and haemostasis 2007;98(2):427-33.
-
2007: Kovacs Alexander; Tornvall Per; Nilsson Roland; Tegnér Jesper; Hamsten Anders; Björkegren Johan
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(34):13768-73.
-
2007: Kolak Maria; Westerbacka Jukka; Velagapudi Vidya R; Wågsäter Dick; Yetukuri Laxman; Makkonen Janne; Rissanen Aila; Häkkinen Anna-Maija; Lindell Monica; Bergholm Robert; Hamsten Anders; Eriksson Per; Fisher Rachel M; Oresic Matej; Yki-Järvinen Hannele
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.
Diabetes 2007;56(8):1960-8.
-
2007: Norata Giuseppe Danilo; Grigore Liliana; Raselli Sara; Redaelli Laura; Hamsten Anders; Maggi Franco; Eriksson Per; Catapano Alberico Luigi
Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies.
Atherosclerosis 2007;193(2):321-7.
-
2007: Mannila M N; Lovely R S; Kazmierczak S C; Eriksson P; Samnegård A; Farrell D H; Hamsten A; Silveira A
Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
Journal of thrombosis and haemostasis : JTH 2007;5(4):766-73.
-
2007: Lundman Pia; Boquist Susanna; Samnegård Ann; Bennermo Marie; Held Claes; Ericsson Carl-Göran; Silveira Angela; Hamsten Anders; Tornvall Per
A high-fat meal is accompanied by increased plasma interleukin-6 concentrations.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(3):195-202.
-
2007: Mannila M N; Eriksson P; Leander K; Wiman B; de Faire U; Hamsten A; Silveira A
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
Journal of internal medicine 2007;261(2):138-47.
-
2007: Kolak Maria; Yki-Järvinen Hannele; Kannisto Katja; Tiikkainen Mirja; Hamsten Anders; Eriksson Per; Fisher Rachel M
Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2007;92(2):720-4.
-
2007: Barlera Simona; Specchia Claudia; Farrall Martin; Chiodini Benedetta D; Franzosi Maria Grazia; Rust Stephan; Green Fiona; Nicolis Enrico B; Peden John; Assmann Gerd; Collins Rory; Hamsten Anders; Tognoni Gianni; Watkins Hugh;
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study.
European journal of human genetics : EJHG 2007;15(2):221-7.
-
2007: van Rooijen Marianne; Silveira Angela; Thomassen Stella; Hansson Lars-Olof; Rosing Jan; Hamsten Anders; Bremme Katarina
Rapid activation of haemostasis after hormonal emergency contraception.
Thrombosis and haemostasis 2007;97(1):15-20.
-
2007: Krapivner S; Chernogubova E; Ericsson M; Ahlbeck-Glader C; Hamsten A; van 't Hooft F M
Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration.
Diabetologia 2007;50(1):94-102.
-
2007: Lundell Kerstin; Thulin Petra; Hamsten Anders; Ehrenborg Ewa
Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.
BMC molecular biology 2007;8():70.
-
2007: Kalani Majid; Silveira Angela; Blombäck Margareta; Apelqvist Jan; Eliasson Björn; Eriksson Jan W; Fagrell Bengt; Torffvit Ole; Hamsten Anders; Jörneskog Gun
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
Thrombosis research 2007;120(5):653-61.
-
2006: Skoog Tiina; Hamsten Anders; Eriksson Per
Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter.
Biochemical and biophysical research communications 2006;351(3):777-83.
-
2006: Gertow K; Rosell M; Sjögren P; Eriksson P; Vessby B; de Faire U; Hamsten A; Hellenius M-L; Fisher R M
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance.
European journal of clinical nutrition 2006;60(12):1406-13.
-
2006: Silveira Angela; Hamsten Anders
Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(11):2419-20.
-
2006: Hulthe Johannes; McPheat William; Samnegård Ann; Tornvall Per; Hamsten Anders; Eriksson Per
Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6.
Atherosclerosis 2006;188(2):450-4.
-
2006: Sheikine Yuri; Bang Charlotte Sahlberg; Nilsson Lennart; Samnegård Ann; Hamsten Anders; Jonasson Lena; Eriksson Per; Sirsjö Allan
Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease.
Atherosclerosis 2006;188(2):462-6.
-
2006: Zhu Chaoyong; Odeberg Jacob; Hamsten Anders; Eriksson Per
Allele-specific MMP-3 transcription under in vivo conditions.
Biochemical and biophysical research communications 2006;348(3):1150-6.
-
2006: Nilsson Lennart; Jonasson Lena; Nijm Johnny; Hamsten Anders; Eriksson Per
Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease.
Clinical chemistry 2006;52(8):1522-7.
-
2006: Casas Juan P; Shah Tina; Cooper Jackie; Hawe Emma; McMahon Alex D; Gaffney Dairena; Packard Christopher J; O'Reilly Denis S; Juhan-Vague Irene; Yudkin John S; Tremoli Elena; Margaglione Maurizio; Di Minno Giovanni; Hamsten Anders; Kooistra Teake; Stephens Jeffrey W; Hurel Steven J; Livingstone Shona; Colhoun Helen M; Miller George J; Bautista Leonelo E; Meade Tom; Sattar Naveed; Humphries Steve E; Hingorani Aroon D
Insight into the nature of the CRP-coronary event association using Mendelian randomization.
International journal of epidemiology 2006;35(4):922-31.
-
2006: Pietiläinen Kirsi H; Kannisto Katja; Korsheninnikova Elena; Rissanen Aila; Kaprio Jaakko; Ehrenborg Ewa; Hamsten Anders; Yki-Järvinen Hannele
Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins.
The Journal of clinical endocrinology and metabolism 2006;91(7):2776-81.
-
2006: Farrall Martin; Green Fiona R; Peden John F; Olsson Per G; Clarke Robert; Hellenius Mai-Lis; Rust Stephan; Lagercrantz Jacob; Franzosi Maria Grazia; Schulte Helmut; Carey Alisoun; Olsson Gunnar; Assmann Gerd; Tognoni Gianni; Collins Rory; Hamsten Anders; Watkins Hugh
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17.
PLoS genetics 2006;2(5):e72.
-
2006: van Rooijen M; Silveira A; Hamsten A; Bremme K
Sex hormone-binding globulin--a surrogate marker for the prothrombic effects of combined oral contraceptives.
American journal of obstetrics and gynecology 2006;194(5):1499.
-
2006: Samnegård A; Silveira A; Tornvall P; Hamsten A; Ericsson C-G; Eriksson P
Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction.
Journal of internal medicine 2006;259(5):530-6.
-
2006: Mallbris Lotus; Granath Fredrik; Hamsten Anders; Ståhle Mona
Psoriasis is associated with lipid abnormalities at the onset of skin disease.
Journal of the American Academy of Dermatology 2006;54(4):614-21.
-
2006: Norata G D; Grigore L; Raselli S; Seccomandi P M; Hamsten A; Maggi F M; Eriksson P; Catapano A L
Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies.
Journal of molecular and cellular cardiology 2006;40(4):484-94.
-
2006: Lundahl Björn; Skoglund-Andersson Camilla; Caslake Muriel; Bedford Dorothy; Stewart Philip; Hamsten Anders; Packard Christopher J; Karpe Fredrik
Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
American journal of physiology. Endocrinology and metabolism 2006;290(4):E739-45.
-
2006: Mannila Maria Nastase; Eriksson Per; Ericsson Carl-Göran; Hamsten Anders; Silveira Angela
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Thrombosis and haemostasis 2006;95(3):420-7.
-
2006: Gustafsson Ida; Malmberg Klas; Rydén Lars; Wedel Hans; Birkeland Kåre; Bootsma Aart; Dickstein Kenneth; Efendic Suad; Fisher Miles; Hamsten Anders; Herlitz Johan; Hildebrandt Per Rossen; MacLeod Kenneth; Laakso Markku; Torp-Pedersen Christian T; Waldenström Anders;
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]
Ugeskrift for laeger 2006;168(6):581-4.
-
2006: van Rooijen M; Hansson L O; Frostegård J; Silveira A; Hamsten A; Bremme K
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response.
Journal of thrombosis and haemostasis : JTH 2006;4(1):77-82.
-
2006: Westerbacka J; Cornér A; Kannisto K; Kolak M; Makkonen J; Korsheninnikova E; Nyman T; Hamsten A; Fisher R M; Yki-Järvinen H
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects.
Diabetologia 2006;49(1):132-40.
-
2006: Ria Massimiliano; Eriksson Per; Boquist Susanna; Ericsson Carl-Göran; Hamsten Anders; Lagercrantz Jacob
Human genetic evidence that OX40 is implicated in myocardial infarction.
Biochemical and biophysical research communications 2006;339(3):1001-6.
-
2006: Kannisto Katja; Chibalin Alexander; Glinghammar Björn; Zierath Juleen R; Hamsten Anders; Ehrenborg Ewa
Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
International journal of molecular medicine 2006;17(1):45-52.
-
2005: Sjogren Per; Basu Samar; Rosell Magdalena; Silveira Angela; de Faire Ulf; Vessby Bengt; Hamsten Anders; Hellenius Mai-Lis; Fisher Rachel M
Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2580-6.
-
2005: Ireland H; Konstantoulas C J; Cooper J A; Hawe E; Humphries S E; Mather H; Goodall A H; Hogwood J; Juhan-Vague I; Yudkin J S; di Minno G; Margaglione M; Hamsten A; Miller G J; Bauer K A; Kim Y T; Stearns-Kurosawa D J; Kurosawa S
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.
Atherosclerosis 2005;183(2):283-92.
-
2005: Samnegård A; Silveira A; Lundman P; Boquist S; Odeberg J; Hulthe J; McPheat W; Tornvall P; Bergstrand L; Ericsson C-G; Hamsten A; Eriksson P
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Journal of internal medicine 2005;258(5):411-9.
-
2005: Pearce Eve; Tregouet David-Alexandre; Samnegård Ann; Morgan Angharad R; Cox Charles; Hamsten Anders; Eriksson Per; Ye Shu
Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction.
Circulation research 2005;97(10):1070-6.
-
2005: Wallander M; Bartnik M; Efendic S; Hamsten A; Malmberg K; Ohrvik J; Rydén L; Silveira A; Norhammar A
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study.
Diabetologia 2005;48(11):2229-35.
-
2005: Bennermo Marie; Held Claes; Ericsson Carl-Göran; Silveira Angela; Hamsten Anders; Tornvall Per
Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction?
Thrombosis and haemostasis 2005;94(2):427-31.
-
2005: Wiklund Per-Gunnar; Nilsson Lennart; Ardnor Sofie Nilsson; Eriksson Per; Johansson Lars; Stegmayr Birgitta; Hamsten Anders; Holmberg Dan; Asplund Kjell
Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
Stroke; a journal of cerebral circulation 2005;36(8):1661-5.
-
2005: Kazi Monsur; Zhu Chaoyong; Roy Joy; Paulsson-Berne Gabrielle; Hamsten Anders; Swedenborg Jesper; Hedin Ulf; Eriksson Per
Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1341-6.
-
2005: Hamsten Anders; Mannila Maria Nastase; Silveira Angela
Quest for genes regulating plasma fibrinogen concentration: still a long way to go.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1100-1.
-
2005: Kovacs Alexander; Henriksson Peter; Hamsten Anders; Wallén Håkan; Björkegren Johan; Tornvall Per
Hormonal regulation of circulating C-reactive protein in men.
Clinical chemistry 2005;51(5):911-3.
-
2005: Lundberg G A; Kellin A; Samnegård A; Lundman P; Tornvall P; Dimmeler S; Zeiher A M; Hamsten A; Hansson G K; Eriksson P
Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene.
Journal of internal medicine 2005;257(5):415-22.
-
2005: Swanberg Maria; Lidman Olle; Padyukov Leonid; Eriksson Per; Akesson Eva; Jagodic Maja; Lobell Anna; Khademi Mohsen; Börjesson Ola; Lindgren Cecilia M; Lundman Pia; Brookes Anthony J; Kere Juha; Luthman Holger; Alfredsson Lars; Hillert Jan; Klareskog Lars; Hamsten Anders; Piehl Fredrik; Olsson Tomas
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
Nature genetics 2005;37(5):486-94.
-
2005: Hamsten Anders; Silveira Angela; Boquist Susanna; Tang Rong; Bond M Gene; de Faire Ulf; Björkegren Johan
The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
Journal of the American College of Cardiology 2005;45(7):1013-7.
-
2005: Morange P E; Saut N; Alessi M C; Frere C; Hawe E; Yudkin J S; Tremoli E; Margaglione M; Di Minno G; Hamsten A; Humphries S E; Juhan-Vague I;
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.
Atherosclerosis 2005;179(2):317-23.
-
2005: Wang Xiaosong; Ria Massimiliano; Kelmenson Peter M; Eriksson Per; Higgins David C; Samnegård Ann; Petros Christina; Rollins Jarod; Bennet Anna M; Wiman Björn; de Faire Ulf; Wennberg Charlotte; Olsson Per G; Ishii Naoto; Sugamura Kazuo; Hamsten Anders; Forsman-Semb Kristina; Lagercrantz Jacob; Paigen Beverly
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility.
Nature genetics 2005;37(4):365-72.
-
2005: Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
European heart journal 2005;26(7):650-61.
-
2005: Ding Bo; Kull Björn; Liu Zhurong; Mottagui-Tabar Salim; Thonberg Håkan; Gu Harvest F; Brookes Anthony J; Grundemar Lars; Karlsson Christina; Hamsten Anders; Arner Peter; Ostenson Claes-Göran; Efendic Suad; Monné Magnus; von Heijne Gunnar; Eriksson Per; Wahlestedt Claes
Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function.
Regulatory peptides 2005;127(1-3):45-53.
-
2005: Mannila Maria Nastase; Eriksson Per; Lundman Pia; Samnegård Ann; Boquist Susanna; Ericsson Carl-Göran; Tornvall Per; Hamsten Anders; Silveira Angela
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction.
Thrombosis and haemostasis 2005;93(3):570-7.
-
2005: Eriksson-Berg Margita; Deguchi Hiroyuki; Hawe Emma; Scanavini Daniela; Orth-Gomér Kristina; Schenck-Gustafsson Karin; Humphries Steve E; Silveira Angela; Hamsten Anders
Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease.
Thrombosis and haemostasis 2005;93(2):351-8.
-
2005: Kovacs Alexander; Green Fiona; Hansson Lars-Olof; Lundman Pia; Samnegård Ann; Boquist Susanna; Ericsson Carl-Göran; Watkins Hugh; Hamsten Anders; Tornvall Per
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein.
Atherosclerosis 2005;178(1):193-8.
-
2005: Tornvall Per; Hamsten Anders; Hansson Lars-Olof; O'Konor Marie-Louise; Ericsson Carl-Göran; Strandberg Lars-Erik; Boavida Antonio; Bergstrand Lott
Plasma C-reactive protein and lipoprotein levels, and progression of coronary artery disease after myocardial infarction treated with thrombolysis.
Cardiology 2005;104(2):65-71.
-
2004: Mannila Maria Nastase; Silveira Angela; Hawe Emma; Eriksson Per; Aillaud Marie Françoise; Juhan-Vague Irene; Yudkin John; Margaglione Maurizio; di Minno Giovanni; Mussoni Luciana; Tremoli Elena; Humphries Steve; Hamsten Anders;
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
Thrombosis and haemostasis 2004;92(6):1240-9.
-
2004: Korstanje Ron; Eriksson Per; Samnegård Ann; Olsson Per G; Forsman-Semb Kristina; Sen Saunak; Churchill Gary A; Rollins Jarod; Harris Stephen; Hamsten Anders; Paigen Beverly
Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans.
Atherosclerosis 2004;177(2):443-50.
-
2004: Sutinen J; Kannisto K; Korsheninnikova E; Nyman T; Ehrenborg E; Andrew R; Wake D J; Hamsten A; Walker B R; Yki-Järvinen H
In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue.
Diabetologia 2004;47(10):1668-71.
-
2004: Norata Giuseppe D; Banfi Cristina; Pirillo Angela; Tremoli Elena; Hamsten Anders; Catapano Alberico L; Eriksson Per
Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization.
British journal of haematology 2004;127(1):97-104.
-
2004: Bartnik M; Malmberg K; Hamsten A; Efendic S; Norhammar A; Silveira A; Tenerz A; Ohrvik J; Rydén L
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
Journal of internal medicine 2004;256(4):288-97.
-
2004: Kannisto Katja; Pietiläinen Kirsi H; Ehrenborg Ewa; Rissanen Aila; Kaprio Jaakko; Hamsten Anders; Yki-Järvinen Hannele
Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.
The Journal of clinical endocrinology and metabolism 2004;89(9):4414-21.
-
2004: Whatling Carl; Björk Hanna; Gredmark Sara; Hamsten Anders; Eriksson Per
Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes.
Journal of lipid research 2004;45(9):1768-76.
-
2004: Edfeldt Kristina; Bennet Anna M; Eriksson Per; Frostegård Johan; Wiman Björn; Hamsten Anders; Hansson Göran K; de Faire Ulf; Yan Zhong-qun
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction.
European heart journal 2004;25(16):1447-53.
-
2004: Yudkin J S; Juhan-Vague I; Hawe E; Humphries S E; di Minno G; Margaglione M; Tremoli E; Kooistra T; Morange P E; Lundman P; Mohamed-Ali V; Hamsten A;
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.
Metabolism: clinical and experimental 2004;53(7):852-7.
-
2004: Sjogren Per; Rosell Magdalena; Skoglund-Andersson Camilla; Zdravkovic Slobodan; Vessby Bengt; de Faire Ulf; Hamsten Anders; Hellenius Mai-Lis; Fisher Rachel M
Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men.
The Journal of nutrition 2004;134(7):1729-35.
-
2004: Klareskog Lars; Hamsten Anders
Statins in rheumatoid arthritis--two birds with one stone?
Lancet 2004;363(9426):2011-2.
-
2004: Gertow K; Pietiläinen K H; Yki-Järvinen H; Kaprio J; Rissanen A; Eriksson P; Hamsten A; Fisher R M
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance.
Diabetologia 2004;47(6):1118-25.
-
2004: Sutinen Jussi; Kannisto Katja; Korsheninnikova Elena; Fisher Rachel M; Ehrenborg Ewa; Nyman Tuulikki; Virkamäki Antti; Funahashi Tohru; Matsuzawa Yuji; Vidal Hubert; Hamsten Anders; Yki-Järvinen Hannele
Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
American journal of physiology. Endocrinology and metabolism 2004;286(6):E941-9.
-
2004: Bennermo Marie; Held Claes; Green Fiona; Strandberg Lars-Erik; Ericsson Carl-Göran; Hansson Lars-Olof; Watkins Hugh; Hamsten Anders; Tornvall Per
Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis.
Atherosclerosis 2004;174(1):157-63.
-
2004: Konstantoulas Constantine; Hawe Emma; Saut Naomi; Yudkin John S; di Minno Giovanni; Margaglione Maurizio; Hamsten Anders; Humphries Steve E; Juhan-Vague Irene; Ireland Helen;
Common variants in the thrombomodulin gene as a risk for myocardial infarction in the north of Europe (HIFMECH Study).
Thrombosis and haemostasis 2004;91(3):628-30.
-
2004: Eriksson Per; Deguchi Hiroyuki; Samnegård Ann; Lundman Pia; Boquist Susanna; Tornvall Per; Ericsson Carl-Göran; Bergstrand Lott; Hansson Lars-Olof; Ye Shu; Hamsten Anders
Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):551-7.
-
2004: van Rooijen M; Silveira A; Hamsten A; Bremme K
Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives.
American journal of obstetrics and gynecology 2004;190(2):332-7.
-
2004: Norata Giuseppe D; Björk Hanna; Hamsten Anders; Catapano Alberico L; Eriksson Per
High-density lipoprotein subfraction 3 decreases ADAMTS-1 expression induced by lipopolysaccharide and tumor necrosis factor-alpha in human endothelial cells.
Matrix biology : journal of the International Society for Matrix Biology 2004;22(7):557-60.
-
2004: Gertow K; Bellanda M; Eriksson P; Boquist S; Hamsten A; Sunnerhagen M; Fisher R M
Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome.
The Journal of clinical endocrinology and metabolism 2004;89(1):392-9.
-
2003: Skogsberg J; McMahon A D; Karpe F; Hamsten A; Packard C J; Ehrenborg E;
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
Journal of internal medicine 2003;254(6):597-604.
-
2003: Lagercrantz Jacob; Bergman Martin; Lundman Pia; Tornvall Per; Hjemdahl Paul; Hamsten Anders; Eriksson Per
No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(8):749-53.
-
2003: Juhan-Vague I; Morange P E; Frere C; Aillaud M F; Alessi M C; Hawe E; Boquist S; Tornvall P; Yudkin J S; Tremoli E; Margaglione M; Di Minno G; Hamsten A; Humphries S E;
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2322-9.
-
2003: Tenerz Ake; Norhammar Anna; Silveira Angela; Hamsten Anders; Nilsson Göran; Rydén Lars; Malmberg Klas
Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.
Diabetes care 2003;26(10):2770-6.
-
2003: Kalani Majid; Apelqvist Jan; Blombäck Margareta; Brismar Kerstin; Eliasson Björn; Eriksson Jan W; Fagrell Bengt; Hamsten Anders; Torffvit Ole; Jörneskog Gun
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
Diabetes care 2003;26(9):2575-80.
-
2003: Bennermo M; Held C; Hamsten A; Strandberg L-E; Ericsson C-G; Hansson L-O; Tornvall P
Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis.
Journal of internal medicine 2003;254(3):244-50.
-
2003: Glinghammar Bjorn; Skogsberg Josefin; Hamsten Anders; Ehrenborg Ewa
PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.
Biochemical and biophysical research communications 2003;308(2):361-8.
-
2003: Kannisto Katja; Sutinen Jussi; Korsheninnikova Elena; Fisher Rachel M; Ehrenborg Ewa; Gertow Karl; Virkamäki Antti; Nyman Tuulikki; Vidal Hubert; Hamsten Anders; Yki-Järvinen Hannele
Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy.
AIDS (London, England) 2003;17(12):1753-62.
-
2003: Norata G D; Pirillo A; Callegari E; Hamsten A; Catapano A L; Eriksson P
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL.
Cardiovascular research 2003;59(1):169-80.
-
2003: Norata Giuseppe D; Pellegatta Fabio; Hamsten Anders; Catapano Alberico L; Eriksson Per
Effects of HDL3 on the expression of matrix-degrading proteases in human endothelial cells.
International journal of molecular medicine 2003;12(1):73-8.
-
2003: Lundman Pia; Eriksson Maria J; Silveira Angela; Hansson Lars-Olof; Pernow John; Ericsson Carl-Göran; Hamsten Anders; Tornvall Per
Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1).
The American journal of cardiology 2003;91(9):1128-31.
-
2003: Tornvall Per; Waeg Georg; Nilsson Jan; Hamsten Anders; Regnström Jan
Autoantibodies against modified low-density lipoproteins in coronary artery disease.
Atherosclerosis 2003;167(2):347-53.
-
2003: Skoglund-Andersson Camilla; Ehrenborg Ewa; Fisher Rachel M; Olivecrona Gunilla; Hamsten Anders; Karpe Fredrik
Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men.
Atherosclerosis 2003;167(2):311-7.
-
2003: Gertow K; Skoglund-Andersson C; Eriksson P; Boquist S; Orth-Gomér K; Schenck-Gustafsson K; Hamsten A; Fisher R M
A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution.
Atherosclerosis 2003;167(2):265-73.
-
2003: Vakkilainen Juha; Steiner George; Ansquer Jean-Claude; Aubin Francois; Rattier Stephanie; Foucher Christelle; Hamsten Anders; Taskinen Marja-Riitta;
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
Circulation 2003;107(13):1733-7.
-
2003: Skogsberg Josefin; Kannisto Katja; Cassel Tobias N; Hamsten Anders; Eriksson Per; Ehrenborg Ewa
Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(4):637-43.
-
2003: Yki-Järvinen Hannele; Sutinen Jussi; Silveira Angela; Korsheninnikova Elena; Fisher Rachel M; Kannisto Katja; Ehrenborg Ewa; Eriksson Per; Hamsten Anders
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(4):688-94.
-
2003: Klareskog Lars; Efendic Suad; Brismar Kerstin; Hamsten Anders
[The proposal of the National Board of Health and Welfare counteracts knowledge development within health care]
Läkartidningen 2003;100(8):631-2.
-
2003: Hamsten Anders; Eriksson Per
Thrombospondins and premature coronary artery disease: time to go beyond genotype-phenotype association studies.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(1):6-7.
-
2003: Skoglund-Andersson C; Karpe F; Hellénius M-L; Regnström J; Hamsten A; Tornvall P
In vitro and in vivo lipolysis of plasma triglycerides increases the resistance to oxidative modification of low-density lipoproteins.
European journal of clinical investigation 2003;33(1):51-7.
-
2002: Fisher R M; Thörne A; Hamsten A; Arner P
Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals.
Molecular and cellular biochemistry 2002;239(1-2):95-100.
-
2002: Björkegren Johan; Silveira Angela; Boquist Susanna; Tang Rong; Karpe Fredrik; Bond M Gene; de Faire Ulf; Hamsten Anders
Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(9):1470-4.
-
2002: Jormsjö Sofia; Wuttge Dirk M; Sirsjö Allan; Whatling Carl; Hamsten Anders; Stemme Sten; Eriksson Per
Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice.
The American journal of pathology 2002;161(3):939-45.
-
2002: Norhammar Anna; Tenerz Ake; Nilsson Göran; Hamsten Anders; Efendíc Suad; Rydén Lars; Malmberg Klas
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.
Lancet 2002;359(9324):2140-4.
-
2002: Juhan-Vague I; Morange P E; Aubert H; Henry M; Aillaud M F; Alessi M C; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries S E;
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(5):867-73.
-
2002: Boquist Susanna; Karpe Fredrik; Danell-Toverud Karin; Hamsten Anders
Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
Atherosclerosis 2002;162(1):163-70.
-
2002: Dichtl Wolfgang; Ares Mikko P S; Jönson Audrey Niemann; Jovinge Stefan; Pachinger Otmar; Giachelli Cecilia M; Hamsten Anders; Eriksson Per; Nilsson Jan
Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation.
Metabolism: clinical and experimental 2002;51(3):327-33.
-
2002: Skoog T; Dichtl W; Boquist S; Skoglund-Andersson C; Karpe F; Tang R; Bond M G; de Faire U; Nilsson J; Eriksson P; Hamsten A
Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.
European heart journal 2002;23(5):376-83.
-
2002: Lundahl Björn; Hamsten Anders; Karpe Fredrik
Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(2):289-93.
-
2002: van Rooijen Marianne; von Schoultz Bo; Silveira Angela; Hamsten Anders; Bremme Katarina
Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.
American journal of obstetrics and gynecology 2002;186(1):44-8.
-
2001: Jormsjö S; Whatling C; Walter D H; Zeiher A M; Hamsten A; Eriksson P
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(11):1834-9.
-
2001: Fisher R M; Eriksson P; Hoffstedt J; Hotamisligil G S; Thörne A; Rydén M; Hamsten A; Arner P
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals.
Diabetologia 2001;44(10):1268-73.
-
2001: van 't Hooft F M; Ruotolo G; Boquist S; de Faire U; Eggertsen G; Hamsten A
Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins.
Circulation 2001;104(11):1223-8.
-
2001: Lundman P; Eriksson M J; Stühlinger M; Cooke J P; Hamsten A; Tornvall P
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine.
Journal of the American College of Cardiology 2001;38(1):111-6.
-
2001: Karpe F; Taskinen M R; Nieminen M S; Frick M H; Kesäniemi Y A; Pasternack A; Hamsten A; Syvänne M
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.
Atherosclerosis 2001;157(1):181-7.
-
2001: Banfi C; Eriksson P; Giandomenico G; Mussoni L; Sironi L; Hamsten A; Tremoli E
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway.
Diabetes 2001;50(7):1522-30.
-
2001: Eriksson-Berg M; Silveira A; Orth-Gomér K; Hamsten A; Schenck-Gustafsson K
Coagulation factor VII in middle-aged women with and without coronary heart disease.
Thrombosis and haemostasis 2001;85(5):787-92.
-
2001: Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen M R; Yki-Järvinen H
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Thrombosis and haemostasis 2001;85(4):619-25.
-
2001: Karpe F; Boquist S; Tang R; Bond G M; de Faire U; Hamsten A
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.
Journal of lipid research 2001;42(1):17-21.
-
2000: Dichtl W; Ares M P; Stollenwerk M; Giachelli C M; Scatena M; Hamsten A; Eriksson P; Nilsson J
In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Thrombosis and haemostasis 2000;84(4):706-11.
-
2000: Silveira A; Schatteman K; Goossens F; Moor E; Scharpé S; Strömqvist M; Hendriks D; Hamsten A
Plasma procarboxypeptidase U in men with symptomatic coronary artery disease.
Thrombosis and haemostasis 2000;84(3):364-8.
-
2000: Björn Lundahl; Leren T P; Ose L; Hamsten A; Karpe F
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1784-8.
-
2000: Skogsberg J; Kannisto K; Roshani L; Gagne E; Hamsten A; Larsson C; Ehrenborg E
Characterization of the human peroxisome proliferator activated receptor delta gene and its expression.
International journal of molecular medicine 2000;6(1):73-81.
-
2000: Ehrenborg E; Skogsberg J; Ruotolo G; Large V; Eriksson P; Arner P; Hamsten A
The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins.
Journal of internal medicine 2000;247(6):651-6.
-
2000: Henney A M; Ye S; Zhang B; Jormsjö S; Whatling C; Eriksson P; Hamsten A
Genetic diversity in the matrix metalloproteinase family. Effects on function and disease progression.
Annals of the New York Academy of Sciences 2000;902():27-37; discussion 37-8.
-
2000: Jormsjö S; Ye S; Moritz J; Walter D H; Dimmeler S; Zeiher A M; Henney A; Hamsten A; Eriksson P
Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.
Circulation research 2000;86(9):998-1003.
-
2000: van't Hooft F M; Lundahl B; Ragogna F; Karpe F; Olivecrona G; Hamsten A
Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(5):1335-9.
-
2000: Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
Thrombosis and haemostasis 2000;83(4):545-8.
-
2000: Moor E; Blombäck M; Silveira A; Wiman B; Cederlund K; Bergstrand L; Ivert T; Rydén L; Hamsten A
Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure.
Thrombosis research 2000;98(1):39-49.
-
2000: Hamsten A; Syvänne M; Silveira A; Luong L A; Nieminen M S; Humphries S; Frick M H; Taskinen M R
Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
Thrombosis and haemostasis 2000;83(3):397-403.
-
2000: Ruotolo G; Båvenholm P; Brismar K; Eféndic S; Ericsson C G; de Faire U; Nilsson J; Hamsten A
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.
Journal of the American College of Cardiology 2000;35(3):647-54.
-
2000: Boquist S; Hamsten A; Karpe F; Ruotolo G
Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men.
Diabetologia 2000;43(2):185-93.
-
2000: Björkegren J; Boquist S; Samnegârd A; Lundman P; Tornvall P; Ericsson C G; Hamsten A
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease.
Circulation 2000;101(3):227-30.
-
1999: van 't Hooft F M; von Bahr S J; Silveira A; Iliadou A; Eriksson P; Hamsten A
Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):3063-70.
-
1999: Dichtl W; Stiko A; Eriksson P; Goncalves I; Calara F; Banfi C; Ares M P; Hamsten A; Nilsson J
Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):3025-32.
-
1999: Zhang B; Henney A; Eriksson P; Hamsten A; Watkins H; Ye S
Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.
Human genetics 1999;105(5):418-23.
-
1999: Skoglund-Andersson C; Tang R; Bond M G; de Faire U; Hamsten A; Karpe F
LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(10):2422-30.
-
1999: van 't Hooft F M; Jormsjö S; Lundahl B; Tornvall P; Eriksson P; Hamsten A
A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein.
Journal of lipid research 1999;40(9):1686-94.
-
1999: Boquist S; Ruotolo G; Tang R; Björkegren J; Bond M G; de Faire U; Karpe F; Hamsten A
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.
Circulation 1999;100(7):723-8.
-
1999: Skoog T; van't Hooft F M; Kallin B; Jovinge S; Boquist S; Nilsson J; Eriksson P; Hamsten A
A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha.
Human molecular genetics 1999;8(8):1443-9.
-
1999: Nilsson L; Takemura T; Eriksson P; Hamsten A
Effects of fibrate compounds on expression of plasminogen activator inhibitor-1 by cultured endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(6):1577-81.
-
1999: Dichtl W; Nilsson L; Goncalves I; Ares M P; Banfi C; Calara F; Hamsten A; Eriksson P; Nilsson J
Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells.
Circulation research 1999;84(9):1085-94.
-
1999: Allison B A; Nilsson L; Karpe F; Hamsten A; Eriksson P
Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(5):1354-60.
-
1999: van 't Hooft F M; Silveira A; Tornvall P; Iliadou A; Ehrenborg E; Eriksson P; Hamsten A
Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.
Blood 1999;93(10):3432-41.
-
1999: Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland D K; Angelin B; Hamsten A; Eriksson P
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor.
Journal of lipid research 1999;40(5):913-9.
-
1999: Zhang B; Ye S; Herrmann S M; Eriksson P; de Maat M; Evans A; Arveiler D; Luc G; Cambien F; Hamsten A; Watkins H; Henney A M
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
Circulation 1999;99(14):1788-94.
-
1999: Karpe F; Hellénius M L; Hamsten A
Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Metabolism: clinical and experimental 1999;48(3):301-7.
-
1999: Wamala S P; Murray M A; Horsten M; Eriksson M; Schenck-Gustafsson K; Hamsten A; Silveira A; Orth-Gomér K
Socioeconomic status and determinants of hemostatic function in healthy women.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):485-92.
-
1998: Karpe F; de Faire U; Mercuri M; Bond M G; Hellénius M L; Hamsten A
Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men.
Atherosclerosis 1998;141(2):307-14.
-
1998: Ruotolo G; Ericsson C G; Tettamanti C; Karpe F; Grip L; Svane B; Nilsson J; de Faire U; Hamsten A
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Journal of the American College of Cardiology 1998;32(6):1648-56.
-
1998: Nilsson L; Banfi C; Diczfalusy U; Tremoli E; Hamsten A; Eriksson P
Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(11):1679-85.
-
1998: Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
Thrombosis and haemostasis 1998;80(2):220-4.
-
1998: Björkegren J; Karpe F; Milne R W; Hamsten A
Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Journal of lipid research 1998;39(7):1412-20.
-
1998: Karpe F; Lundahl B; Ehrenborg E; Eriksson P; Hamsten A
A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(5):756-61.
-
1998: Boquist S; Ruotolo G; Hellénius M L; Danell-Toverud K; Karpe F; Hamsten A
Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
Atherosclerosis 1998;137(2):391-400.
-
1998: Båvenholm P; de Faire U; Landou C; Efendic S; Nilsson J; Wiman B; Hamsten A
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.
European heart journal 1998;19(3):402-10.
-
1998: Regnström J; Jovinge S; Båvenholm P; Ericsson C G; De Faire U; Hamsten A; Hellenius M L; Nilsson J; Tornvall P
Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease.
Journal of internal medicine 1998;243(2):109-13.
-
1998: Björkegren J; Karpe F; Vitols S; Tornvall P; Hamsten A
Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro.
Journal of lipid research 1998;39(2):423-36.
-
1998: Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
Diabetologia 1998;41(1):65-71.
-
1998: Eriksson P; Nilsson L; Karpe F; Hamsten A
Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(1):20-6.
-
1998: Jovinge S; Hamsten A; Tornvall P; Proudler A; Båvenholm P; Ericsson C G; Godsland I; de Faire U; Nilsson J
Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.
Metabolism: clinical and experimental 1998;47(1):113-8.
-
1997: Ericsson C G; Nilsson J; Grip L; Svane B; Hamsten A
Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]).
The American journal of cardiology 1997;80(9):1125-9.
-
1997: Rydén L; Hamsten A
The way ahead in the management of unstable coronary artery disease.
The American journal of cardiology 1997;80(5A):64E-67E.
-
1997: de Faire U; Ericsson C G; Grip L; Nilsson J; Svane B; Hamsten A
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11 Suppl 1():257-63.
-
1997: Karpe F; Olivecrona T; Hamsten A; Hultin M
Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.
Journal of lipid research 1997;38(5):949-61.
-
1997: Malmberg K; Rydén L; Hamsten A; Herlitz J; Waldenström A; Wedel H
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.
Cardiovascular research 1997;34(1):248-53.
-
1997: Björkegren J; Hamsten A; Milne R W; Karpe F
Alterations of VLDL composition during alimentary lipemia.
Journal of lipid research 1997;38(2):301-14.
-
1996: de Faire U; Ericsson C G; Grip L; Nilsson J; Svane B; Hamsten A
Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
European heart journal 1996;17 Suppl F():37-42.
-
1996: Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
Metabolism: clinical and experimental 1996;45(11):1375-82.
-
1996: Silveira A; Karpe F; Johnsson H; Bauer K A; Hamsten A
In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(11):1333-9.
-
1996: Fatah K; Silveira A; Tornvall P; Karpe F; Blombäck M; Hamsten A
Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
Thrombosis and haemostasis 1996;76(4):535-40.
-
1996: Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall A H; Eriksson M; Angelin B; Hjemdahl P
Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
Thrombosis and haemostasis 1996;76(2):171-6.
-
1996: Ericsson C G; Hamsten A; Nilsson J; Grip L; Svane B; de Faire U
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.
Lancet 1996;347(9005):849-53.
-
1996: Regnström J; Nilsson J; Moldeus P; Ström K; Båvenholm P; Tornvall P; Hamsten A
Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease.
The American journal of clinical nutrition 1996;63(3):377-85.
-
1996: Bjorkegren J; Packard C J; Hamsten A; Bedford D; Caslake M; Foster L; Shepherd J; Stewart P; Karpe F
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway.
Journal of lipid research 1996;37(1):76-86.
-
1995: Frostegård J; Regnström J; Tornvall P; Hamsten A; Nilsson J
The susceptibility of low density lipoprotein to chemical oxidation is closely related to proneness to biological modification.
Free radical research 1995;23(6):581-92.
-
1995: Båvenholm P; Karpe F; Proudler A; Tornvall P; Crook D; Hamsten A
Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype.
Metabolism: clinical and experimental 1995;44(11):1481-8.
-
1995: Båvenholm P; Proudler A; Tornvall P; Godsland I; Landou C; de Faire U; Hamsten A
Insulin, intact and split proinsulin, and coronary artery disease in young men.
Circulation 1995;92(6):1422-9.
-
1995: Tornvall P; Regnström J; Hamsten A
Cellular processing of apolipoprotein B-containing lipoproteins from young post-infarction patients and healthy controls.
European journal of clinical investigation 1995;25(9):699-707.
-
1995: Tornvall P; Olivecrona G; Karpe F; Hamsten A; Olivecrona T
Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(8):1086-93.
-
1995: Karpe F; Hamsten A
Postprandial lipoprotein metabolism and atherosclerosis.
Current opinion in lipidology 1995;6(3):123-9.
-
1995: Moor E; Silveira A; van't Hooft F; Suontaka A M; Eriksson P; Blombäck M; Hamsten A
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(5):655-64.
-
1995: Båvenholm P; Proudler A; Silveira A; Crook D; Blombäck M; de Faire U; Hamsten A
Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease.
Thrombosis and haemostasis 1995;73(4):568-75.
-
1995: Eriksson P; Kallin B; van 't Hooft F M; Båvenholm P; Hamsten A
Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(6):1851-5.
-
1995: Karpe F; Bell M; Björkegren J; Hamsten A
Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(2):199-207.
-
1995: de Faire U; Ericsson C G; Hamsten A; Nilsson J
Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Drugs under experimental and clinical research 1995;21(3):105-24.
-
1994: Silveira A; Green F; Karpe F; Blombäck M; Humphries S; Hamsten A
Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism.
Thrombosis and haemostasis 1994;72(5):734-9.
-
1994: Hamsten A; Eriksson P; Karpe F; Silveira A
Relationships of thrombosis and fibrinolysis to atherosclerosis.
Current opinion in lipidology 1994;5(5):382-9.
-
1994: Karpe F; Hamsten A
Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
Journal of lipid research 1994;35(7):1311-7.
-
1994: Moor E; Hamsten A; Karpe F; Båvenholm P; Blombäck M; Silveira A
Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
Thrombosis and haemostasis 1994;71(6):707-12.
-
1994: Karpe F; Steiner G; Uffelman K; Olivecrona T; Hamsten A
Postprandial lipoproteins and progression of coronary atherosclerosis.
Atherosclerosis 1994;106(1):83-97.
-
1994: Regnström J; Tornvall P; Kallner A; Nilsson J; Hamsten A
Stored iron levels and myocardial infarction at young age.
Atherosclerosis 1994;106(1):123-5.
-
1994: Hamsten A; Karpe F; Båvenholm P; Silveira A
Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease.
Journal of internal medicine. Supplement 1994;736():75-88.
-
1993: Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
Circulation 1993;88(5 Pt 1):2180-9.
-
1993: Asplund-Carlson A; Hamsten A; Wiman B; Carlson L A
Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.
Diabetologia 1993;36(9):817-25.
-
1993: Ericsson C G; Hamsten A; Landou C; Mesko L; Müller-Suur R; Nilsson J; De Faire U
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptoms.
European heart journal 1993;14(7):891-7.
-
1993: Karpe F; Steiner G; Olivecrona T; Carlson L A; Hamsten A
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
The Journal of clinical investigation 1993;91(3):748-58.
-
1993: Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson L A; Hamsten A
Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Atherosclerosis 1993;98(1):33-49.
-
1993: Karpe F; Bard J M; Steiner G; Carlson L A; Fruchart J C; Hamsten A
HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(1):11-22.
-
1993: Hamsten A
Lipids as a coronary risk factor: analysis of hyperlipidaemias.
Postgraduate medical journal 1993;69 Suppl 1():S8-11.
-
1992: Nilsson J; Volk-Jovinge S; Svensson J; Landou C; De Faire U; Hamsten A
Association between high levels of growth factors in plasma and progression of coronary atherosclerosis.
Journal of internal medicine 1992;232(5):397-404.
-
1992: Stiko-Rahm A; Hultgårdh-Nilsson A; Regnström J; Hamsten A; Nilsson J
Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(9):1099-109.
-
1992: Fatah K; Hamsten A; Blombäck B; Blombäck M
Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
Thrombosis and haemostasis 1992;68(2):130-5.
-
1992: Ericsson C G; Erhardt L; Hamsten A; Mesko L; Szamosi A; Zetterquist S; de Faire U
Does diffuse coronary atherosclerosis affect the relation between coronary stenoses and uptake of thallium-201 after exercise?
Clinical physiology (Oxford, England) 1992;12(4):475-85.
-
1992: Regnström J; Nilsson J; Tornvall P; Landou C; Hamsten A
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man.
Lancet 1992;339(8803):1183-6.
-
1991: Tornvall P; Karpe F; Carlson L A; Hamsten A
Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
Atherosclerosis 1991;90(1):67-80.
-
1991: Johansson J; Nilsson-Ehle P; Carlson L A; Hamsten A
The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age.
Atherosclerosis 1991;86(2-3):111-22.
-
1991: Johansson J; Carlson L A; Landou C; Hamsten A
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(1):174-82.
-
1990: Stiko-Rahm A; Wiman B; Hamsten A; Nilsson J
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Arteriosclerosis (Dallas, Tex.) 1990;10(6):1067-73.
-
1990: Tornvall P; Hamsten A; Carlson L A
Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemia.
Atherosclerosis 1990;82(1-2):125-35.
-
1990: Frostegård J; Nilsson J; Haegerstrand A; Hamsten A; Wigzell H; Gidlund M
Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(3):904-8.
-
1990: Frostegård J; Hamsten A; Gidlund M; Nilsson J
Low density lipoprotein-induced growth of U937 cells: a novel method to determine the receptor binding of low density lipoprotein.
Journal of lipid research 1990;31(1):37-44.
-
1990: Gustafsson C; Blombäck M; Britton M; Hamsten A; Svensson J
Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.
Stroke; a journal of cerebral circulation 1990;21(1):47-51.
-
1988: Hamsten A
Apolipoproteins, dyslipoproteinaemia and premature coronary heart disease.
Acta medica Scandinavica 1988;223(5):389-403.
-
1987: Urdén G; Hamsten A; Wiman B
Comparison of plasminogen activator inhibitor activity and antigen in plasma samples.
Clinica chimica acta; international journal of clinical chemistry 1987;169(2-3):189-96.
-
1987: Hamsten A; Iselius L; de Faire U; Blombäck M
Genetic and cultural inheritance of plasma fibrinogen concentration.
Lancet 1987;2(8566):988-91.
-
1987: Hamsten A; de Faire U; Walldius G; Dahlén G; Szamosi A; Landou C; Blombäck M; Wiman B
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
Lancet 1987;2(8549):3-9.
-
1986: Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Circulation 1986;73(6):1097-110.
-
1984: Lindvall K; Hamsten A; Landou C; Szamosi A; de Faire U
Comparative study of echo- and angiocardiographically determined regional left ventricular wall motion in recent myocardial infarction.
European heart journal 1984;5(7):533-44.
Sign-in to see more